PDCD1 and autoimmune disease: Consistent with human evidence of polymorphisms associated with SLE, T1D (Type 1 diabetes mellitus), and RA, experimental animal models of T1D-prone mice (73) and collagen-induced arthritis (CIA) (32) indicate that PD-1 activation attenuates autoimmune disease.